The partnership will integrate Ellipsis Health’s clinical-grade mental health screening technology into Ceras Health’s clinical monitoring platform to improve assessment and care.
SAN FRANCISCO, August 11, 2022 /PRNewswire/ — Ellipsis Healththe market leader in AI-generated voice biomarker technology, and Waxes Health, a leader in digital health solutions, today announced a partnership that will integrate Ellipsis Health’s cutting-edge technology that uses the human voice as a biomarker for mental health and wellness into Ceras’ clinical monitoring platform. This integration will combine Ellipsis Health’s artificial intelligence and deep learning technology with Ceras Health’s clinical monitoring and health data analytics platform, enabling real-time severity scores for anxiety and depression to improve care. and classify patients who need it.
Currently, mental health conditions are at epidemic proportions. In the USA, 28 percent of people have depression, while 36 percent suffer from anxiety¹, and 41 percent reported mental health disorders in the last year, twice as many as in 2019². The National Alliance on Mental Health estimates that 55 percent of people with mental illness are not receiving treatment, and there is a projected shortage of up to 30,000 psychiatrists in the US by 2024. This explosive growth, coupled with the difficulty of accessing appropriate treatment for many populations, is part of the impetus for the Ellipsis Health and Ceras Health partnership. Together, the companies plan to provide greater access to mental health treatment for the more than 18 million Medicare patients with mental health problems.
“This new partnership will advance the state of mental health care, allowing Ellipsis Health to put its cutting-edge voice technology to work, identifying people in need and then connecting them with integrated behavioral health services.,” said Mainul Mondal, founder and CEO of Ellipsis Health. “We are proud to partner with Ceras Health, an organization that shares our commitment to using innovative technology to ensure those who need it have access to the right care at the right time, with the potential to transform the way you identify, oversees and manages the mental health care delivered.”
By bringing technology-driven innovation to mental health care, Ellipsis Health is giving voice to a new standard of care, pioneering the only clinically validated vital sign for mental health. By harnessing the unique power of the human voice as a biomarker for mental wellness, coupled with machine learning and AI, Ellipsis Health identifies, measures and monitors the severity of stress, anxiety and depression at scale. Its technology analyzes a short speech sample to create an objective and scalable clinical decision support tool.
“This unique partnership with Ellipsis Health aligns with Ceras Health’s commitment to delivering impactful care to our chronically ill patients and innovating the way we deliver this care,” said Udaya Devinini, Executive Director (CEO) of Ceras. “The ability to access mental health care has never been more important given these unprecedented times, especially for those patients who also manage chronic illnesses, and we are excited about the potential to give patients easy and direct access to mental health support.
Ceras Health will use Ellipsis Health technology in its digital transitions of care solutions that are transforming the way health care is delivered, especially for Medicare and other vulnerable populations. Using a combination of 24/7 clinical expertise, remote patient monitoring, artificial intelligence (AI), and advanced data analytics, Ceras Health solutions combine clinical expertise and tools to help patients get the personalized care they need to drive improvements in their health outcomes.
About Ellipsis Health
Ellipsis Health was founded on the belief that a person’s mental health should be given the same priority as physical health. The company saw an opportunity to connect the dots between the two: giving voice to a new standard of mental health care. By harnessing the unique power of the human voice as a biomarker for mental wellness, coupled with machine learning and artificial intelligence, Ellipsis Health has established the only clinically validated vital sign for mental health. Its technology identifies, measures and monitors the severity of stress, anxiety and depression at scale by analyzing a short speech sample to create an objective and scalable clinical decision support tool. Through partnerships with providers, payers, employers and digital health companies, Ellipsis Health is working to positively impact quality of care, shorten time to diagnosis, drive workflow efficiency, reduce costs and improve outcomes. from the patients. To learn more about Ellipsis Health, visit https://www.ellipsishealth.com.
About Ceras Salud
Ceras Health is a pioneer provider of digital health solutions utilizing clinical expertise and 24/7 remote monitoring, AI and advanced analytics, connected health devices, and a personalized behavior change and gamification platform. to help and empower patients through their care transitions. Ceras partners with health systems, providers and payers to provide solutions to vulnerable populations to improve their health outcomes and care experience through digital care with a human touch. For more information about Ceras Health, visit www.cerashealth.com Or email [email protected].
¹ https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm
² https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a1.htm?s_cid=mm6932a1_x
SOURCE Ellipsis Health
.
